Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery (a randomized, double-blind, multi-center, placebo-controlled study)

Trial Profile

Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery (a randomized, double-blind, multi-center, placebo-controlled study)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jan 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs TJ 100 (Primary)
  • Indications Colon cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2018 Results of a pooled retrospective subset analysis from 39-0902, 40-1001, and 42-1002 trials presented at the 2018 Gastrointestinal Cancers Symposium
    • 03 Mar 2017 New trial record
    • 24 Feb 2017 A pooled analysis of three randomized controlled trials (UMIN000001592, UMIN000003103 and UMIN000004693) is being conducted and is registered in UMIN (UMIN000026292, Daikenchuto for enhancement of bowel movement after open abdominal surgery: a pooled analysis of three randomized controlled trials) with primary endpoint 'the time from the first meal after extubation to the first evacuation'.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top